Review Topical Sections

Integrated strategies for type 2 diabetes prevention: The role of diet and exercise

  • These two authors contributed equally.
  • Received: 30 September 2024 Revised: 02 March 2025 Accepted: 17 March 2025 Published: 08 April 2025
  • Background 

    Type 2 diabetes (T2D) is a prevalent global health problem largely caused by lifestyle factors, including poor diet and physical inactivity. With the increasing incidence of T2D, effective prevention strategies are urgently needed. This review examines the role of different dietary patterns and exercise regimens in the prevention and management of T2D, focusing on their effects on glycemic control, insulin sensitivity, and cardiovascular health.

    Methods 

    A narrative review was conducted synthesizing evidence from clinical trials, cohort studies, and meta-analyses. The review focused on the effects of low-carbohydrate diets (LCDs), Mediterranean diets (MDs), plant-based diets, high-protein diets (HPDs), and various exercise regimens, including aerobic, resistance, and high-intensity interval training (HIIT).

    Results 

    Dietary interventions, particularly MD and plant-based diets, are associated with improved glycemic control and reduced risk of developing T2D. LCDs show short-term benefits for weight management and HbA1c reduction, although adherence remains a challenge. HPDs show mixed results, with some benefits for lipid profiles but inconsistent effects on glycemic control. Exercise programs, especially combined aerobic and resistance training, significantly improve glycemic control, insulin sensitivity, and cardiovascular risk factors. HIIT emerges as an effective option for improving metabolic health in individuals at risk for or living with T2D.

    Conclusions 

    A combination of dietary modification and physical activity, particularly Mediterranean and plant-based diets coupled with combined aerobic and resistance exercise, appears to be the most effective strategy for the prevention and management of T2D. Future research should focus on personalized approaches that integrate both diet and exercise to tailor interventions to individual patient needs.

    Citation: Nicola Tecce, Mattia Proganò, Davide Menafra, Annamaria Docimo, Stefano Zarrilli, Roberta Scairati, Anna Lisa Pelosi, Rosario Pivonello, Annamaria Colao. Integrated strategies for type 2 diabetes prevention: The role of diet and exercise[J]. AIMS Public Health, 2025, 12(2): 418-450. doi: 10.3934/publichealth.2025024

    Related Papers:

    [1] Andrea M. Auxier, Bonni D. Hopkins, Anne E. Reins . Under Construction: One States Approach to Creating Health Homes for Individuals with Serious Mental Illness. AIMS Public Health, 2015, 2(2): 163-182. doi: 10.3934/publichealth.2015.2.163
    [2] Meghan Fondow, Nancy Pandhi, Jason Ricco, Elizabeth Zeidler Schreiter, Lauren Fahey, Neftali Serrano, Marguerite Burns, Elizabeth A. Jacobs . Visit Patterns for Severe Mental Illness with Implementation of Integrated Care: A Pilot Retrospective Cohort Study. AIMS Public Health, 2015, 2(4): 821-831. doi: 10.3934/publichealth.2015.4.821
    [3] Susanne Klawetter, Jennifer C. Greenfield, Stephanie Rachel Speer, Kyria Brown, Sunah S. Hwang . An integrative review: maternal engagement in the neonatal intensive care unit and health outcomes for U.S.-born preterm infants and their parents. AIMS Public Health, 2019, 6(2): 160-183. doi: 10.3934/publichealth.2019.2.160
    [4] Bethany M. Kwan, Aimee B. Valeras, Shandra Brown Levey, Donald E. Nease, Mary E. Talen . An Evidence Roadmap for Implementation of Integrated Behavioral Health under the Affordable Care Act. AIMS Public Health, 2015, 2(4): 691-717. doi: 10.3934/publichealth.2015.4.691
    [5] LauraM.Daniels, KimE.Dixon, LisaC.Campbell . Building Capacity for Behavioral Health Services and Clinical Research in a Rural Primary Care Clinic: A Case Study. AIMS Public Health, 2014, 1(2): 60-75. doi: 10.3934/publichealth.2014.2.60
    [6] Jessie-Lee McIsaac, Grace Warner, Logan Lawrence, Robin Urquhart, Sheri Price, Jacqueline Gahagan, Mary McNally, Lois A Jackson . The application of implementation science theories for population health: A critical interpretive synthesis. AIMS Public Health, 2018, 5(1): 13-30. doi: 10.3934/publichealth.2018.1.13
    [7] Larrell L. Wilkinson, Saundra H. Glover, Janice C. Probst, Bo Cai, Lisa T. Wigfall . Psychological Distress and Health Insurance Coverage among Formerly Incarcerated Young Adults in the United States. AIMS Public Health, 2015, 2(3): 227-246. doi: 10.3934/publichealth.2015.3.227
    [8] Bernadette M. Pauly, Sana Z. Shahram, Phuc T. H. Dang, Lenora Marcellus, Marjorie MacDonald . Health Equity Talk: Understandings of Health Equity among Health Leaders. AIMS Public Health, 2017, 4(5): 490-512. doi: 10.3934/publichealth.2017.5.490
    [9] Cynthia M. LeRouge, Donghua Tao, Jennifer Ohs, Helen W. Lach, Keri Jupka, Ricardo Wray . Challenges and Opportunities with Empowering Baby Boomers for Personal Health Information Management Using Consumer Health Information Technologies: an Ecological Perspective. AIMS Public Health, 2014, 1(3): 160-181. doi: 10.3934/publichealth.2014.3.160
    [10] Calum F Leask, Andrea Gilmartin . Implementation of a neighbourhood care model in a Scottish integrated context—views from patients. AIMS Public Health, 2019, 6(2): 143-153. doi: 10.3934/publichealth.2019.2.143
  • Background 

    Type 2 diabetes (T2D) is a prevalent global health problem largely caused by lifestyle factors, including poor diet and physical inactivity. With the increasing incidence of T2D, effective prevention strategies are urgently needed. This review examines the role of different dietary patterns and exercise regimens in the prevention and management of T2D, focusing on their effects on glycemic control, insulin sensitivity, and cardiovascular health.

    Methods 

    A narrative review was conducted synthesizing evidence from clinical trials, cohort studies, and meta-analyses. The review focused on the effects of low-carbohydrate diets (LCDs), Mediterranean diets (MDs), plant-based diets, high-protein diets (HPDs), and various exercise regimens, including aerobic, resistance, and high-intensity interval training (HIIT).

    Results 

    Dietary interventions, particularly MD and plant-based diets, are associated with improved glycemic control and reduced risk of developing T2D. LCDs show short-term benefits for weight management and HbA1c reduction, although adherence remains a challenge. HPDs show mixed results, with some benefits for lipid profiles but inconsistent effects on glycemic control. Exercise programs, especially combined aerobic and resistance training, significantly improve glycemic control, insulin sensitivity, and cardiovascular risk factors. HIIT emerges as an effective option for improving metabolic health in individuals at risk for or living with T2D.

    Conclusions 

    A combination of dietary modification and physical activity, particularly Mediterranean and plant-based diets coupled with combined aerobic and resistance exercise, appears to be the most effective strategy for the prevention and management of T2D. Future research should focus on personalized approaches that integrate both diet and exercise to tailor interventions to individual patient needs.



    Social and Behavioral Determinants of Health (SBDH), a combination of behavioral, social, economic, environmental, and occupational factors, are powerful drivers of morbidity, mortality, and future well-being, yet they mostly lie outside the domain of the conventional medical care delivery system [1]. While these modifiable behaviors and community exposures (defined either geographically or by other means such as race) play a significant role in 60% of preventable deaths in the U.S., direct medical services account for more than 95% of the trillion dollars spent on healthcare annually [2]. Despite U.S. having the highest per capita medical expenditures of any country in history, the limited investments in non-medical services might play a role in the U.S. health indicators lagging behind most other high-income nations [3].

    To help mitigate potential negative impacts of key SBDH risk factors, healthcare organizations need to address these underlying factors at the overall neighborhood level as well as within focused sub-groups of high-risk individuals. Investment in behavioral and social services, and connecting high-need patients to these services, would improve the health outcomes and reduce the cost of services for healthcare organizations [4]. For instance, a reduction of preventable hospitalization among residents of low-income neighborhoods in the U.S. to the level of those living in high-income neighborhoods would lead to 500,000 fewer hospitalizations per year, saving $3.6 billion in hospitalization costs [4].

    In the last several years, U.S. federal, state, and private payers have initiated a series of policies and programs to improve the value of healthcare. These initiatives generally emphasize financial incentives to increase the quality of care and reduce healthcare costs [5]. In order for clinicians and health delivery systems to navigate and succeed within these “pay for performance” programs, they must better address social and behavioral risk factors within their target population. Some of these factors are linked to the individual patient, but where the patient lives is also a major determinant, or at least a correlate, of SBDH related risk [6][8]. Without considering SBDH factors in decision-making and program development, the special needs of high-cost patients who are concomitantly facing socioeconomic challenges and behavioral health problems might not be properly addressed thus resulting in providers to be penalized financially [6],[7][9].

    Therefore, understanding patients' individual social and behavioral risk factors in addition to the socio-environmental context of the neighborhood in which the patient resides and the impact of those socio-environmental inequalities on behavioral factors is critical to assess the level of achievement of health and wellbeing [7]. Accordingly, for healthcare organizations which provide services to patients with social and behavioral risk factors and those from the neighborhoods with significant levels of non-medical risk factors, a formal assessment of the SBDH related challenges and needs for individual patients and within patients' communities is essential for designing both individual and population level responses and interventions. Without this SBDH assessment it would be difficult, if not impossible, to provide good care or to succeed within value-based delivery systems [8],[9].

    Despite the importance and significant impact of SBDH and place of living on health, medical care providers rarely have tools available to incorporate information about patients' social and behavioral risks, and neighborhood characteristics into clinical or organizational decision-making [1]. Inclusion of such individual-level SBDH as well as environmental SBDH related risks into decision-making frameworks requires a systematic approach to identify and respond to those factors that have the highest impact on health outcomes and cost [10],[11]. This response can occur either at the patient care level, for subpopulations (e.g., for a cohort enrolled within a patient-centered medical home or PCMH), or for a neighborhood at-large (e.g., certain target neighborhoods, city, county, or higher level) [12],[13].

    As one of the largest integrated health systems in the country, the Veterans Health Administration (VHA) is increasingly interested in the development of tools and health indicators that take into account SBDH factors of the veterans and those associated with their communities [14][16]. Unlike most medical providers, the VHA has a statutory commitment to address both the medical and non-medical needs of their patients.

    The overarching goal of the project reported here was to help VHA better address SBDH risk factors for the veterans it cares within its PCMH program. In the VHA, these primary care organizational units are termed Patient-Aligned Care Teams, or PACT [17]. The premise of this project was that these SBDH factors affect the use of healthcare services and outcomes for each of the VHA's primary care clinics, and thus individual patient level socio-behavioral factors in addition to the geographically linked factors could add information beyond medical factors mostly considered in clinical decision making, patient care, and population health. While some of these modifiable SBDH risk factors can be addressed at a primary care clinic, there are community exposures that must be addressed by population-level programs.

    To achieve this goal we first undertook a literature review and environmental scan which guided us to develop a conceptual framework. The framework showed how practices could use such social, behavioral, or geo-linked data for patient care, risk prediction models, risk adjustment programs, or population-level analytics for population health. The review also resulted in proposing an initial evidence-based set of measures and available data sources. The measures, using recommended SBDH domains by the National Academy of Medicine [18] were reflective of individual and population-level SBDH relevant to primary care settings that could, for most patients and neighborhoods, be documented based on existing electronic data sets. We narrowed the list of SBDH domains after completing the literature review, consulting with clinicians and researchers who collected and used SBDH data regularly, gauging the basic data availability of domain-specific SBDH factors, and high-level VHA priorities.

    While we did not perform a systematic literature review our review included a number of databases such as PubMed, Web of Science, and Google Scholar. We used the articles identified through the PubMed search to start a snowball sample. In addition, we selected gray literature found via Google. We used keywords such as “Patient-Centered Care”, “Social and Behavioral Determinants of Health”, and “Electronic Medical Records”. The search resulted in 1848 articles. After an initial assessment we narrowed down our review to selected articles that utilized social, behavioral, and geo-coded data in primary care settings, specifically in PCMH clinics. We included conceptual papers and commentaries, as well as case studies or quantitative analyses of a single site or program. We also included studies addressing the role of social and behavioral factors in assessment of hospitalization and readmission in a primary care setting.

    Figure 1 presents an evidence-based framework to address SBDH and to integrate them in the analytic platforms in the VHA's PCMH program [1],[11],[19][21]. It presents the conceptual representation of the VHA's delivery system, including relevant inputs, throughputs, and outputs. Specifically, the graphic outlines Key Social, behavioral, and Clinical Risk Factors—in the leftmost box—as important inputs and categories of Key Patient and Population Level Outcomes—in the rightmost box—as key outputs of care provided to veterans enrolled in the VHA's PCMH program. We posit that ideally all of these factors need to be measured, monitored, and managed. Social and Behavioral risk factors are listed in details in table 1 and the appendix table. The tables also include a comprehensive list of evidence-based measures and their data sources.

    Figure 1.  A conceptual framework for integrating patient and population-level data to address social and behavioral determinants of health in the VHA's primary care clinics.

    CAN Score: Care Assessment Needs Score which reflects estimated probability of admission or death within a specified time period (90 days or 1 year); CHOICE Program: a benefit that allows eligible veterans to receive healthcare from a community provider rather than waiting for a VHA appointment or traveling to a VHA facility; PACT: Patient-Aligned Care Team, type of Patient-Centered Medical Home; SBDH: Social and Behavioral Determinants of Health; VHA: Veterans Health Administration.

    The large middle box depicts the care delivery system for veterans. At the top we summarize the key structural components, including the PACT—the PCMH initiative, the CHOICE program—a benefit that allows eligible veterans to receive covered care from providers in their neighborhood instead of a lengthy wait or long trip to be seen within a VHA facility, and other non-VHA care that veterans may receive.

    The center box on the figure also presents the Levels of Care Intervention that reflects how SBDH and other risk factors can be addressed within the VHA as a large integrated delivery system. At the first level, SBDH factors' incorporation could help clinicians to better address socio-behavioral risk factors among patients within their patient panel. At the second level the VHA provider network could better design programs addressing “high-need, high-cost” patients. And at the third level VHA and other government agencies could use the risk factor information for those veteran communities, who are experiencing high levels of socio-behavioral risk and may require special outreach programs to address those in need [13].

    The throughput part of the conceptual framework (bottom center box of Figure 1) is our summation of key aspects of the optimal Patient & Population Health Analytics process that the VHA providers could undertake using digitally collected SBDH information. The left-most part of this box outlines three Analytics Supported Tasks. These include: (1) Patient Care & Management, where SBDH factors could be used to help augment clinical interventions and clinically-oriented high-risk case identification as well as predictive models. For instance, SBDH risk factors for individual veterans and those associated with the veteran's neighborhood could be added into the VHA's medically oriented Care Assessment Need (CAN) score [22] which is now used to help estimate probability of admission at a specified time period; (2) Risk Stratification, where SBDH factors help adjust for potential differences in outcomes or costs [23]. For instance, the VHA could consider stratifying for different socioeconomic factors of veterans when assessing primary care quality metrics or resource expenditures; (3) Community Assessment, where SBDH information could play a key role in targeting communities or sub-populations with the highest risk and thus the best targets for special programmatic interventions. It is also possible that changes in the level of social and behavioral risk factors could serve as end-points and outcomes in their own right, helping to assess the impact of VHA population health programs.

    The right part of the bottom population health analytics box acknowledges the three potential SBDH Data Sources obtained from each of the entities: The individual patient/consumer, the healthcare organization, and from sources associated with government or private entities that comprise the infrastructure of a geographically defined community. It should be noted that each of the data sources may be used to accomplish any of the three analytics supported tasks noted in the adjacent box to the left, or they may be used to target interventions at any of the three levels of care intervention noted in the adjacent box above. For example, consumer surveys on social and behavioral risk could be used at the patient level or agammaegated across a PCMH or neighborhood (as is the case of the U.S. Census Bureau's American Community Survey or ACS) [24]. Another example would be risk factors derived from a provider's electronic health record (EHR). These data could be used to identify social and behavioral risk factors that are agammaegated at the patient, clinic, or neighborhood level. Neighborhood characteristics (e.g., poor housing stock) can likewise be linked to patients or organization, in addition to neighborhoods from which the data are collected [16].

    A key component of the proposed framework is the set of social, behavioral, and clinical risk factors in the leftmost box. To address these factors we recommended a comprehensive set of individual and population-level social and behavioral risk measures associated with individual veterans and the communities where they reside. We recommended SBDH risk factors for consideration relevant for integration into the analytic platforms of VHA's PCMH program or other VHA's patient-and population-oriented initiatives. Table 1 presents the SBDH domains and sub-domains, using National Academy of Medicine recommendations [18].

    The recommended SBDH domains suggested in Table 1 include those related to service provision, geographic and individual linked health determinants, and medical, social, and behavioral outcomes. They address major SBDH impacting health such as sociodemographic, psychosocial, and behavioral characteristics [10], different aspects of housing [1],[20],[25][35] such as homelessness, housing insecurity, and characteristics of housing. Physical and built environment issues affecting walkability and access to healthcare, such as geographic characteristics of the living space, access to different modes of transportation, and social characteristics of the neighborhood such as safety are addressed as well [36][40]. It is also important to assess the role of psychosocial factors on accessibility of healthcare services. While it is rather widely observed that people with limited socioeconomic resources have limited access to healthcare, some vulnerable populations are less likely to recognize the importance of regular usage of primary healthcare, due to a wide range of psychosocial factors. Issues related to diet and food systems, namely access to healthy food options, public assistance food access, and healthy food habits [1],[18][45]; and socioeconomic issues such as income, education, employment, and neighborhood socioeconomic status are also presented [1],[20].

    Table 1.  Domains of social and behavioral determinants of health for consideration in VHA primary care clinics*.
    SBDH Domains SBDH Sub-domains
    Sociodemographic Sexual Orientation
    Race/Ethnicity
    Country of Origin
    Education
    Employment
    Financial Resource Strain Food Insecurity Public Assistance Food Access
    Individual's Food Intake
    Housing Insecurity**
    Psychological Health Literacy
    Stress
    Negative Mood & Affect Depression
    Anxiety
    Psychological Assets Self-efficacy, Conscientiousness, Patient engagement/Activation, Optimism
    Behavioral Dietary Patterns Healthy Food Habits
    Physical Activity
    Tobacco Use and Exposure
    Alcohol Use
    Social Relationship Social Connection and Social Isolation
    Violence Exposure
    Neighborhood Compositional Characteristics Natural Environment Air Quality
    Water Quality
    Childhood Lead Poisoning Levels
    Physical/Built Environment Housing Housing Characteristics
    Housing Insecurity**
    Homelessness
    Walkability and Access Geographic Characteristics of Living Space
    Mode of transportation
    Walkability Index
    Street Connectivity
    Access to Healthy Food Options
    Access to Healthcare Facility
    Socio-economic Social Deprivation
    Social Characteristics of Neighborhood Income
    Education
    Employment
    Neighborhood Socioeconomic Index
    Economic Distress
    Healthcare Access
    Race/Ethnicity Neighborhood-level Racial Residential Segregation

    Note: * The conceptual framework is presented in Figure 1. This table expands on categories of social and behavioral determinants of health (red circle in the figure) using recommendations from National Academy of Medicine.

    ** There are overlaps among different domains of SBDH. For instance, housing insecurity would be included in two domains.

    SBDH: Social and Behavioral Determinants of Health; VHA: Veterans Health Administration.

     | Show Table
    DownLoad: CSV

    In an appendix table, we provide a set of measures for each subdomain of SBDH. We considered these measures an initial set for the VHA's PCMH program to complement current SBDH measures available to them. The individual level and neighborhood linked SBDH were selected from a much larger set of candidate domains and measures based on the results of the literature review [10],[26],[46][54]. We assessed evidence on the relationship of SBDH with meaningful health outcomes or other endpoints, the availability of reliable measures, and the existence of digital data sources to allow measurement in the majority of locales across the U.S. We then narrowed down the list of measures to those presented. Table 2 presents our selection criteria for SBDH measures [55]. While this list includes a wide range of SDBH it is not an exhaustive one. In the past few years a large number of studies have assessed the impact of different SBDH on health outcomes and healthcare utilization.

    As noted, we also provided an assessment of potential available data sources for each sub-category of social and behavioral factors not currently available in the VHA's electronic databases. The appended table of recommended SBDH measures and URL links to the current database or other resources can be used to calculate the SBDH relevant metrics on a population level and in most neighborhoods. The table also includes recommendations for inclusion of SBDH on a patient level in the VHA's electronic databases.

    Table 2.  Selection criteria for social and behavioral determinants measures.
    Categories Characteristics
    Patient vs. Population/Neighborhood Focused Relevant to patient or neighborhood level interventions
    Health System Interventions (e.g., VHA PCMH)
    Bringing population issues into clinical services (e.g. PCP, care manager, or outreach nurse)
    Importance/Applicability Patient or Population-based performance measures
    Factors that are important to take into account for patient care and population health interventions
    Development of a Balanced Score Card for Patient Care and Population Health Measures not related to clinical care (i.e., behavioral and social)
    Focusing on population facets of clinical care (i.e., the full denominator of those in need not just those getting care)
    Focusing on interplay between patient care and population health interventions
    A type of structure oriented QI measure that will serve as a motivator to help build new infrastructure for data collection for patient care and population health (e.g., a metric assessing the collection of SES data in EHRs)
    Tools that will support not just the current interventions, but also future innovations
    Relevant to small areas, i.e. when defining communities, we can go beyond just county or zip code
    Range of temporality, some measures address short term outcomes, others address longer-term outcomes
    Overall Practicality and Strategic Value Measurement areas previously addressed but where further work is needed
    Could be accomplished with limited resources (e.g., not a new major neighborhood survey)
    Fills a gap on the comprehensive framework we developed
    Data Feasibility/Supports and Expands digital infrastructure Data currently are available digitally or could be available in next few years
    Capitalizes and expands on new data assets (e.g., EHR)
    Scientific Evidence/Measures Attributes Some evidence that measures matter for health and welfare
    Ideally some preliminary measurement work exists
    Some previous validation of accuracy/feasibility desirable
    Some previous measure standards/certification desirable

    Note: EHR: Electronic Health Record, PCMH: Patient-Centered Medical Home, PCP: Primary Care Provider, QI: Quality Improvement, SES: Socio-economic Status, VHA: Veterans Health Administration.

     | Show Table
    DownLoad: CSV

    It is important to note that while some U.S. EHR vendors have started adding specific fields for collecting SBDH, no universally accepted and standardized format currently exists for documenting SBDH in EHRs [18],[33],[56][59]. Major efforts are underway to increase the standardized vocabulary and content of EHR data across the U.S. [60],[61], which would eventually impact the quality and coverage of SBDH documentation in EHRs. For example, Centers for Medicare and Medicaid Services (CMS) required the collection of demographic information including race, ethnicity, and preferred language, and smoking status as the core measures in stage 1 of the Meaningful Use (MU) program [62]. Also, CMS now requires that all in-scope clinicians apply standardized processes and definitions within their certified EHR to screen for and document SBDH concerning food security, employment, and housing [63]. Such initiatives are fiscally backed by Medicare and might offer a successful framework for the collection of consistent SBDH data across EHRs. While these initiatives do not directly impact VHA, the standardized approach to SBDH documentation in EHRs will eventually affect all EHR systems across the spectrum of healthcare organizations.

    A number of challenges should be addressed in order to systematically identify and respond to the socio-behavioral factors that have the highest impact on health outcomes and healthcare cost. VHA, similar to most of the care delivery systems in the country and other healthcare organizations, lacks analytic frameworks to incorporate information about patients' social and behavioral risk and neighborhood characteristics into clinical or organizational decision-making. They also lack access to SBDH data sources in the electronic databases for each sub-domain of social and behavioral factors on a patient level, for subpopulations, or for a neighborhood at-large [11]. Most healthcare organizations often use administrative claims and structured EHRs for assessment of SBDH, which lacks in-depth assessment of important social and behavioral factors affecting health, such as housing issues and food insecurity. The limited access to data on social and behavioral factors through EHRs' unstructured free-text, which requires time-consuming and subjective methods such as chart review for identification of patients with high social and behavioral risk, is not a feasible approach for screening a large population of patients [25],[46],[48],[63]. Application of supplementary social and behavioral data on a population level from national surveys such as ACS by the U.S. Census Bureau [24] or limited clinic-based surveys are not easily available across different populations and healthcare organizations [25],[46].

    The evidence-based framework and the initial set of individual and neighborhood level social and behavioral risk measures that we proposed here would help to develop analytic platforms for systematic identification of SBDH and their integration in clinical decision supports and different levels of care within VHA and other large integrated delivery systems as well as smaller, less-integrated systems. Increased integration of such information into patient care could allow the physicians and other clinicians to tailor personalized care and modulate care coordination efforts as needed [11],[13]. Examples here include a clinician's knowledge of a diabetic patient's social and behavioral risk factors such as living in a food desert or having food insecurity would help them to provide personalized recommendations regarding their weight management. It would also help the physician in connecting the patient to potential social services such as Supplemental Nutrition Assistance Program (SNAP) and Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) programs [64],[13].

    Our framework also presented the key aspects of the optimal analytics process that VHA's PCMH program or other integrated providers would undertake to perform analytics-supported tasks such as patient care and management, risk stratification, and community assessment, using digitally collected SBDH information [55]. The optimal analytics process could facilitate the community engagement to strengthen links between clinics and community resources [65].

    The three proposed potential SBDH data sources obtained from the individual patient/consumer, the healthcare organizations, and from a geographically defined neighborhood could guide VHA and other healthcare organizations to link data within their organization and to supplement social and behavioral data on a population level. This linkage of different data sources would enable them to address SBDH in their decision-making and program development while investing in standardized processes to document SBDH and collect high-quality patient-level data for SBDH assessment.

    Linking population-level data such as those obtained by the U.S. Census Bureau [24] to data collected in EHRs and other clinical and administrative patient-level information systems helps to identify patients at risk of poor health outcomes and high social needs. Assessing the geographic variations in health outcomes and healthcare utilization such as hospitalization and emergency department visits based on demographic, clinical, and socioeconomic factors could also signal differential access to care and disparities in quality of care [47]. The application of placed-based data to assess disparities at the geographic level or other population approaches in healthcare is a powerful tool for case management purposes of underserved populations. Using data available in small geographic areas such as a census tract or block group can help in identifying those neighborhoods with low socioeconomic characteristics suffering from different social and health issues which require intervention; and, provide evidence to support healthcare policies and resource allocation to patients and communities in need.

    Using population level SBDH data would be the best option when the intervention is designed at a neighborhood level (e.g., eliminating food desserts) or when there is lack of individual level data for a specific issue (e.g., how far a patient lives from a food outlet). However, in other instances, when interventions are designed at the individual-level and data is available using individual-level data is more informative. For instance, the economic status of an individual patient and the economic profile of the neighborhood in which she lives are both important, but the former has a more important impact on healthcare utilization and health outcomes.

    Our proposed framework and recommended SBDH metrics can provide a road map for VHA and other primary care-centric healthcare organizations wishing to use the analytic tools to better understand how SBDH affect health outcomes. It would enable them to target their limited care management resources to “high-need, high-cost” patients and would provide the platform for health systems and public health agencies to collaborate in improving the health of the population [55],[66]. Future research should assess the impact of such systematic approach to identification of SBDH at different levels of care within a healthcare system on health outcomes and utilization of healthcare services.


    Acknowledgments



    This project was funded under the National Recovery and Resilience Plan (NRRP), Mission 4, Component 2, Investment 1.3—Call for tender No. 341 of 15 March 2022 of the Italian Ministry of University and research funded by the European Union–NextGenerationEU; award number: project code PE00000003, Concession Decree No. 1550 of 11 October 2022, adopted by the Italian Ministry of University and Research, CUP C53C22000840001, project title: “ON Foods—Research and Innovation Network on Food and Nutrition Sustainability, Safety and Security—Working ON Foods”.

    Authors' contribution



    Nicola Tecce and Mattia Proganò contributed equally to this work and share first authorship. Annamaria Colao served as senior author and supervised the project. Davide Menafra and Annamaria Docimo contributed to the literature search and manuscript drafting. Stefano Zarrilli and Roberta Scairati participated in the data analysis and interpretation. Anna Lisa Pelosi supported the methodological review. Rosario Pivonello contributed to the critical revision of the manuscript. All authors read and approved the final version of the manuscript.

    Conflict of interest



    The authors declare no conflict of interest.

    [1] Diabetes Prevention Program Research Group.Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol (2015) 3: 866-875. https://doi.org/10.1016/S2213-8587(15)00291-0
    [2] Cho NH, Shaw JE, Karuranga S, et al. (2018) IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 138: 271-281. https://doi.org/10.1016/j.diabres.2018.02.023
    [3] Magliano DJ, Boyko EJ (2021) IDF Diabetes Atlas 10th edition scientific committee, IDF DIABETES ATLAS [Internet] 10th ed. Brussels: International Diabetes Federation.
    [4] Willett WC, Dietz WH, Colditz GA (1999) Guidelines for healthy weight. N Engl J Med 341: 427-434. https://doi.org/10.1056/NEJM199908053410607
    [5] Prospective Studies Collaboration.Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet (2009) 373: 1083-1096. https://doi.org/10.1016/S0140-6736(09)60318-4
    [6] Hu FB, Manson JE, Stampfer MJ, et al. (2001) Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 345: 790-797. https://doi.org/10.1056/NEJMoa010492
    [7] Tabák AG, Jokela M, Akbaraly TN, et al. (2009) Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 373: 2215-2221. https://doi.org/10.1016/S0140-6736(09)60619-X
    [8] Al-Sulaiti H, Diboun I, Agha MV, et al. (2019) Metabolic signature of obesity-associated insulin resistance and type 2 diabetes. J Transl Med 17: 348. https://doi.org/10.1186/s12967-019-2096-8
    [9] Neeland IJ, Turer AT, Ayers CR, et al. (2012) Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA 308: 1150-1159. https://doi.org/10.1001/2012.jama.11132
    [10] Blüher M (2014) Are metabolically healthy obese individuals really healthy?. Eur J Endocrinol 171: R209-219. https://doi.org/10.1530/EJE-14-0540
    [11] Phillips CM (2013) Metabolically healthy obesity: definitions, determinants and clinical implications. Rev Endocr Metab Disord 14: 219-227. https://doi.org/10.1007/s11154-013-9252-x
    [12] Ding C, Chan Z, Magkos F (2016) Lean, but not healthy: the ‘metabolically obese, normal-weight’ phenotype. Curr Opin Clin Nutr Metab Care 19: 408-417. https://doi.org/10.1097/MCO.0000000000000317
    [13] Lindström J, Louheranta A, Mannelin M, et al. (2003) The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 26: 3230-3236. https://doi.org/10.2337/diacare.26.12.3230
    [14] Myette-Côté É, Durrer C, Neudorf H, et al. (2018) The effect of a short-term low-carbohydrate, high-fat diet with or without postmeal walks on glycemic control and inflammation in type 2 diabetes: a randomized trial. Am J Physiol Regul Integr Comp Physiol 315: R1210-R1219. https://doi.org/10.1152/ajpregu.00240.2018
    [15] Ajala O, English P, Pinkney J (2013) Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr 97: 505-516. https://doi.org/10.3945/ajcn.112.042457
    [16] Arena R, Sagner M, Byrne NM, et al. (2017) Novel approaches for the promotion of physical activity and exercise for prevention and management of type 2 diabetes. Eur J Clin Nutr 71: 858-864. https://doi.org/10.1038/ejcn.2017.53
    [17] Bull FC, Al-Ansari SS, Biddle S, et al. (2020) World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med 54: 1451-1462. https://doi.org/10.1136/bjsports-2020-102955
    [18] Sigal RJ, Kenny GP, Boulé NG, et al. (2007) Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes: a randomized trial. Ann Intern Med 147: 357-369. https://doi.org/10.7326/0003-4819-147-6-200709180-00005
    [19] Winding KM, Munch GW, Iepsen UW, et al. (2018) The effect on glycaemic control of low-volume high-intensity interval training versus endurance training in individuals with type 2 diabetes. Diabetes Obes Metab 20: 1131-1139. https://doi.org/10.1111/dom.13198
    [20] Earnest CP, Johannsen NM, Swift DL, et al. (2014) Aerobic and strength training in concomitant metabolic syndrome and type 2 diabetes. Med Sci Sports Exerc 46: 1293-1301. https://doi.org/10.1249/MSS.0000000000000242
    [21] Papadopoulou SK, Nikolaidis PT (2023) Low-Carbohydrate Diet and Human Health. Nutrients 15: 2004. https://doi.org/10.3390/nu15082004
    [22] Barzegar M, Afghan M, Tarmahi V, et al. (2021) Ketogenic diet: overview, types, and possible anti-seizure mechanisms. Nutr Neurosci 24: 307-316. https://doi.org/10.1080/1028415X.2019.1627769
    [23] World Health OrganizationCarbohydrate intake for adults and children: WHO guideline (2023). [cited 2025 March 21]. Available from: https://www.who.int/publications/i/item/9789240073593
    [24] Abbasi J (2018) Interest in the Ketogenic Diet Grows for Weight Loss and Type 2 Diabetes. JAMA 319: 215-217. https://doi.org/10.1001/jama.2017.20639
    [25] Brouns F (2018) Overweight and diabetes prevention: is a low-carbohydrate-high-fat diet recommendable?. Eur J Nutr 57: 1301-1312. https://doi.org/10.1007/s00394-018-1636-y
    [26] van Wyk HJ, Davis RE, Davies JS (2016) A critical review of low-carbohydrate diets in people with Type 2 diabetes. Diabet Med 33: 148-157. https://doi.org/10.1111/dme.12964
    [27] Hall KD (2017) A review of the carbohydrate-insulin model of obesity. Eur J Clin Nutr 71: 323-326. https://doi.org/10.1038/ejcn.2016.260
    [28] Moreno B, Bellido D, Sajoux I, et al. (2014) Comparison of a very low-calorie-ketogenic diet with a standard low-calorie diet in the treatment of obesity. Endocrine 47: 793-805. https://doi.org/10.1007/s12020-014-0192-3
    [29] Feinman RD, Fine EJ (2007) Nonequilibrium thermodynamics and energy efficiency in weight loss diets. Theor Biol Med Model 4: 27. https://doi.org/10.1186/1742-4682-4-27
    [30] Dorans KS, Bazzano LA, Qi L, et al. (2022) Effects of a Low-Carbohydrate Dietary Intervention on Hemoglobin A1c: A Randomized Clinical Trial. JAMA Netw Open 5: e2238645. https://doi.org/10.1001/jamanetworkopen.2022.38645
    [31] Samkani A, Skytte MJ, Kandel D, et al. (2018) A carbohydrate-reduced high-protein diet acutely decreases postprandial and diurnal glucose excursions in type 2 diabetes patients. Br J Nutr 119: 910-917. https://doi.org/10.1017/S0007114518000521
    [32] Skytte MJ, Samkani A, Petersen AD, et al. (2019) A carbohydrate-reduced high-protein diet improves HbA1c and liver fat content in weight stable participants with type 2 diabetes: a randomised controlled trial. Diabetologia 62: 2066-2078. https://doi.org/10.1007/s00125-019-4956-4
    [33] Snorgaard O, Poulsen GM, Andersen HK, et al. (2017) Systematic review and meta-analysis of dietary carbohydrate restriction in patients with type 2 diabetes. BMJ Open Diabetes Res Care 5: e000354. https://doi.org/10.1136/bmjdrc-2016-000354
    [34] Davis C, Bryan J, Hodgson J, et al. (2015) Definition of the Mediterranean Diet; a Literature Review. Nutrients 7: 9139-9153. https://doi.org/10.3390/nu7115459
    [35] Dominguez LJ, Di Bella G, Veronese N, et al. (2021) Impact of Mediterranean Diet on Chronic Non-Communicable Diseases and Longevity. Nutrients 13: 2028. https://doi.org/10.3390/nu13062028
    [36] Trichopoulou A (2021) Mediterranean diet as intangible heritage of humanity: 10 years on. Nutr Metab Cardiovasc Dis 31: 1943-1948. https://doi.org/10.1016/j.numecd.2021.04.011
    [37] Jannasch F, Kröger J, Schulze MB, et al. (2017) Dietary Patterns and Type 2 Diabetes: A Systematic Literature Review and Meta-Analysis of Prospective Studies. J Nutr 147: 1174-1182. https://doi.org/10.3945/jn.116.242552
    [38] Milenkovic T, Bozhinovska N, Macut D, et al. (2021) Mediterranean Diet and Type 2 Diabetes Mellitus: A Perpetual Inspiration for the Scientific World. A Review. Nutrients 13: 1307. https://doi.org/10.3390/nu13041307
    [39] Pavlidou E, Papadopoulou SK, Fasoulas A, et al. (2023) Diabesity and Dietary Interventions: Evaluating the Impact of Mediterranean Diet and Other Types of Diets on Obesity and Type 2 Diabetes Management. Nutrients 16: 34. https://doi.org/10.3390/nu16010034
    [40] Estruch R, Ros E, Salas-Salvadó J, et al. (2018) Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. N Engl J Med 378: e34. https://doi.org/10.1056/NEJMoa1800389
    [41] Churuangsuk C, Hall J, Reynolds A, et al. (2022) Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission. Diabetologia 65: 14-36. https://doi.org/10.1007/s00125-021-05577-2
    [42] Panagiotakos DB, Tzima N, Pitsavos C, et al. (2007) The association between adherence to the Mediterranean diet and fasting indices of glucose homoeostasis: the ATTICA Study. J Am Coll Nutr 26: 32-38. https://doi.org/10.1080/07315724.2007.10719583
    [43] Koloverou E, Panagiotakos DB, Pitsavos C, et al. (2016) Adherence to Mediterranean diet and 10-year incidence (2002-2012) of diabetes: correlations with inflammatory and oxidative stress biomarkers in the ATTICA cohort study. Diabetes Metab Res Re 32: 73-81. https://doi.org/10.1002/dmrr.2672
    [44] Gnagnarella P, Dragà D, Misotti AM, et al. (2018) Validation of a short questionnaire to record adherence to the Mediterranean diet: An Italian experience. Nutr Metab Cardiovasc Dis 28: 1140-1147. https://doi.org/10.1016/j.numecd.2018.06.006
    [45] Melina V, Craig W, Levin S, et al. (2016) Position of the Academy of Nutrition and Dietetics: Vegetarian Diets. J Acad Nutr Diet 116: 1970-1980. https://doi.org/10.1016/j.jand.2016.09.025
    [46] Craig WJ, Mangels AR, Fresán U, et al. (2021) The Safe and Effective Use of Plant-Based Diets with Guidelines for Health Professionals. Nutrients 13: 4144. https://doi.org/10.3390/nu13114144
    [47] McMacken M, Shah S (2017) A plant-based diet for the prevention and treatment of type 2 diabetes. J Geriatr Cardiol 14: 342-354. https://doi.org/10.11909/j.issn.1671-5411.2017.05.009
    [48] Baothman OA, Zamzami MA, Taher I, et al. (2016) The role of Gut Microbiota in the development of obesity and Diabetes. Lipids Health Dis 15: 108. https://doi.org/10.1186/s12944-016-0278-4
    [49] Kim Y, Keogh JB, Clifton PM (2016) Polyphenols and Glycemic Control. Nutrients 8: 17. https://doi.org/10.3390/nu8010017
    [50] Kim Y, Keogh J, Clifton P (2015) A review of potential metabolic etiologies of the observed association between red meat consumption and development of type 2 diabetes mellitus. Metabolism 64: 768-779. https://doi.org/10.1016/j.metabol.2015.03.008
    [51] Nolan CJ, Larter CZ (2009) Lipotoxicity: why do saturated fatty acids cause and monounsaturates protect against it?. J Gastroenterol Hepatol 24: 703-706. https://doi.org/10.1111/j.1440-1746.2009.05823.x
    [52] Qian F, Liu G, Hu FB, et al. (2019) Association Between Plant-Based Dietary Patterns and Risk of Type 2 Diabetes: A Systematic Review and Meta-analysis. JAMA Intern Med 179: 1335-1344. https://doi.org/10.1001/jamainternmed.2019.2195
    [53] Li J, Glenn AJ, Yang Q, et al. (2022) Dietary Protein Sources, Mediating Biomarkers, and Incidence of Type 2 Diabetes: Findings From the Women's Health Initiative and the UK Biobank. Diabetes Care 45: 1742-1753. https://doi.org/10.2337/dc22-0368
    [54] Papier K, Appleby PN, Fensom GK, et al. (2019) Vegetarian diets and risk of hospitalisation or death with diabetes in British adults: results from the EPIC-Oxford study. Nutr Diabetes 9: 7. https://doi.org/10.1038/s41387-019-0074-0
    [55] Key TJ, Papier K, Tong TYN (2021) Plant-based diets and long-term health: findings from the EPIC-Oxford study. Proc Nutr Soc 81: 190-198. https://doi.org/10.1017/S0029665121003748
    [56] Ley SH, Ardisson Korat AV, Sun Q, et al. (2016) Contribution of the Nurses' Health Studies to Uncovering Risk Factors for Type 2 Diabetes: Diet, Lifestyle, Biomarkers, and Genetics. Am J Public Health 106: 1624-1630. https://doi.org/10.2105/AJPH.2016.303314
    [57] Malik VS, Fung TT, van Dam RM, et al. (2012) Dietary patterns during adolescence and risk of type 2 diabetes in middle-aged women. Diabetes Care 35: 12-18. https://doi.org/10.2337/dc11-0386
    [58] Pounis GD, Tyrovolas S, Antonopoulou M, et al. (2010) Long-term animal-protein consumption is associated with an increased prevalence of diabetes among the elderly: the Mediterranean Islands (MEDIS) study. Diabetes Metab 36: 484-490. https://doi.org/10.1016/j.diabet.2010.06.007
    [59] Weickert MO, Roden M, Isken F, et al. (2011) Effects of supplemented isoenergetic diets differing in cereal fiber and protein content on insulin sensitivity in overweight humans. Am J Clin Nutr 94: 459-471. https://doi.org/10.3945/ajcn.110.004374
    [60] Moon J, Koh G (2020) Clinical Evidence and Mechanisms of High-Protein Diet-Induced Weight Loss. J Obes Metab Syndr 29: 166-173. https://doi.org/10.7570/jomes20028
    [61] Hansen TT, Astrup A, Sjödin A (2021) Are Dietary Proteins the Key to Successful Body Weight Management? A Systematic Review and Meta-Analysis of Studies Assessing Body Weight Outcomes after Interventions with Increased Dietary Protein. Nutrients 13: 3193. https://doi.org/10.3390/nu13093193
    [62] Magkos F (2020) Protein-Rich Diets for Weight Loss Maintenance. Curr Obes Rep 9: 213-218. https://doi.org/10.1007/s13679-020-00391-0
    [63] Stentz FB, Mikhael A, Kineish O, et al. (2021) High protein diet leads to prediabetes remission and positive changes in incretins and cardiovascular risk factors. Nutr Metab Cardiovasc Dis 31: 1227-1237. https://doi.org/10.1016/j.numecd.2020.11.027
    [64] Clina JG, Sayer RD, Pan Z, et al. (2023) High- and normal-protein diets improve body composition and glucose control in adults with type 2 diabetes: a randomized trial. Obesity (Silver Spring) 31: 2021-2030. https://doi.org/10.1002/oby.23815
    [65] Yu Z, Nan F, Wang LY, et al. (2020) Effects of high-protein diet on glycemic control, insulin resistance and blood pressure in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials. Clin Nutr 39: 1724-1734. https://doi.org/10.1016/j.clnu.2019.08.008
    [66] Jing T, Zhang S, Bai M, et al. (2023) Effect of Dietary Approaches on Glycemic Control in Patients with Type 2 Diabetes: A Systematic Review with Network Meta-Analysis of Randomized Trials. Nutrients 15: 3156. https://doi.org/10.3390/nu15143156
    [67] Gérard C, Vidal H (2019) Impact of Gut Microbiota on Host Glycemic Control. Front Endocrinol (Lausanne) 10: 29. https://doi.org/10.3389/fendo.2019.00029
    [68] Xu YH, Gao CL, Guo HL, et al. (2018) Sodium butyrate supplementation ameliorates diabetic inflammation in db/db mice. J Endocrinol 238: 231-244. https://doi.org/10.1530/JOE-18-0137
    [69] Psichas A, Sleeth ML, Murphy KG, et al. (2015) The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents. Int J Obes (Lond) 39: 424-9. https://doi.org/10.1038/ijo.2014.153
    [70] van Deuren T, Blaak EE, Canfora EE (2022) Butyrate to combat obesity and obesity-associated metabolic disorders: Current status and future implications for therapeutic use. Obes Rev 23: e13498. https://doi.org/10.1111/obr.13498
    [71] Harsch IA, Konturek PC (2018) The Role of Gut Microbiota in Obesity and Type 2 and Type 1 Diabetes Mellitus: New Insights into “Old” Diseases. Med Sci (Basel) 6: 32. https://doi.org/10.3390/medsci6020032
    [72] Aydin Ö, Nieuwdorp M, Gerdes V (2018) The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes. Curr Diab Rep 18: 55. https://doi.org/10.1007/s11892-018-1020-6
    [73] Schwiertz A, Taras D, Schäfer K, et al. (2010) Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 18: 190-195. https://doi.org/10.1038/oby.2009.167
    [74] Gurung M, Li Z, You H, et al. (2020) Role of gut microbiota in type 2 diabetes pathophysiology. EBioMedicine 51: 102590. https://doi.org/10.1016/j.ebiom.2019.11.051
    [75] Horowitz JF, Klein S (2000) Lipid metabolism during endurance exercise. Am J Clin Nutr 72: 558S-5563S. https://doi.org/10.1093/ajcn/72.2.558S
    [76] Howley ET (2001) Type of activity: resistance, aerobic and leisure versus occupational physical activity. Med Sci Sports Exerc 33: S364-369. https://doi.org/10.1097/00005768-200106001-00005
    [77] Muscella A, Stefàno E, Lunetti P, et al. (2020) The Regulation of Fat Metabolism During Aerobic Exercise. Biomolecules 10: 1699. https://doi.org/10.3390/biom10121699
    [78] Houten SM, Wanders RJ (2010) A general introduction to the biochemistry of mitochondrial fatty acid β-oxidation. J Inherit Metab Dis 33: 469-477. https://doi.org/10.1007/s10545-010-9061-2
    [79] Jeukendrup AE (2002) Regulation of fat metabolism in skeletal muscle. Ann N Y Acad Sci 967: 217-235. https://doi.org/10.1111/j.1749-6632.2002.tb04278.x
    [80] Ruegsegger GN, Booth FW (2018) Health Benefits of Exercise. Cold Spring Harb Perspect Med 8: a029694. https://doi.org/10.1101/cshperspect.a029694
    [81] Colberg SR, Albright AL, Blissmer BJ, et al. (2010) Exercise and type 2 diabetes: American College of Sports Medicine and the American Diabetes Association: joint position statement. Exercise and type 2 diabetes. Med Sci Sports Exerc 42: 2282-2303. https://doi.org/10.1249/MSS.0b013e3181eeb61c
    [82] Lochte L, Nielsen KG, Petersen PE, et al. (2016) Childhood asthma and physical activity: a systematic review with meta-analysis and Graphic Appraisal Tool for Epidemiology assessment. BMC Pediatr 16: 50. https://doi.org/10.1186/s12887-016-0571-4
    [83] Ross R, Dagnone D, Jones PJ, et al. (2000) Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med 133: 92-103. https://doi.org/10.7326/0003-4819-133-2-200007180-00008
    [84] Marson EC, Delevatti RS, Prado AK, et al. (20166) Effects of aerobic, resistance, and combined exercise training on insulin resistance markers in overweight or obese children and adolescents: A systematic review and meta-analysis. Prev Med 93: 211-218. https://doi.org/10.1016/j.ypmed.2016.10.020
    [85] Malin SK, Kirwan JP (2012) Fasting hyperglycaemia blunts the reversal of impaired glucose tolerance after exercise training in obese older adults. Diabetes Obes Metab 14: 835-841. https://doi.org/10.1111/j.1463-1326.2012.01608.x
    [86] Wang Y, Li H, Yang D, et al. (2023) Effects of aerobic exercises in prediabetes patients: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 14: 1227489. https://doi.org/10.3389/fendo.2023.1227489
    [87] Phielix E, Meex R, Moonen-Kornips E, et al. (2010) Exercise training increases mitochondrial content and ex vivo mitochondrial function similarly in patients with type 2 diabetes and in control individuals. Diabetologia 53: 1714-1721. https://doi.org/10.1007/s00125-010-1764-2
    [88] Winnick JJ, Sherman WM, Habash DL, et al. (2008) Short-term aerobic exercise training in obese humans with type 2 diabetes mellitus improves whole-body insulin sensitivity through gains in peripheral, not hepatic insulin sensitivity. J Clin Endocrinol Metab 93: 771-778. https://doi.org/10.1210/jc.2007-1524
    [89] Kirwan JP, Solomon TP, Wojta DM, et al. (2009) Effects of 7 days of exercise training on insulin sensitivity and responsiveness in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 297: E151-156. https://doi.org/10.1152/ajpendo.00210.2009
    [90] Pérez-Martin A, Raynaud E, Mercier J (2001) Insulin resistance and associated metabolic abnormalities in muscle: effects of exercise. Obes Rev 2: 47-59. https://doi.org/10.1046/j.1467-789x.2001.00024.x
    [91] Umpierre D, Ribeiro PA, Kramer CK, et al. (2011) Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis. JAMA 305: 1790-1799. https://doi.org/10.1001/jama.2011.576
    [92] Sampath Kumar A, Maiya AG, Shastry BA, et al. (2019) Exercise and insulin resistance in type 2 diabetes mellitus: A systematic review and meta-analysis. Ann Phys Rehabil Med 62: 98-103. https://doi.org/10.1016/j.rehab.2018.11.001
    [93] Boulé NG, Kenny GP, Haddad E, et al. (2003) Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in Type 2 diabetes mellitus. Diabetologia 46: 1071-1081. https://doi.org/10.1007/s00125-003-1160-2
    [94] Kadoglou NP, Iliadis F, Angelopoulou N, et al. (2007) The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus. Eur J Cardiovasc Prev Rehabil 14: 837-843. https://doi.org/10.1097/HJR.0b013e3282efaf50
    [95] Leong DP, Teo KK, Rangarajan S, et al. (2015) Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet 386: 266-273. https://doi.org/10.1016/S0140-6736(14)62000-6
    [96] Celis-Morales CA, Petermann F, Hui L, et al. (2017) Associations Between Diabetes and Both Cardiovascular Disease and All-Cause Mortality Are Modified by Grip Strength: Evidence From UK Biobank, a Prospective Population-Based Cohort Study. Diabetes Care 40: 1710-1718. https://doi.org/10.2337/dc17-0921
    [97] Lu Y, Li G, Ferrari P, et al. (2022) Associations of handgrip strength with morbidity and all-cause mortality of cardiometabolic multimorbidity. BMC Med 20: 191. https://doi.org/10.1186/s12916-022-02389-y
    [98] Felig P, Owen OE, Wahren J, et al. (1969) Amino acid metabolism during prolonged starvation. J Clin Invest 48: 584-594. https://doi.org/10.1172/JCI106017
    [99] Cruz-Jentoft AJ, Bahat G, Bauer J, et al. (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48: 601. https://doi.org/10.1093/ageing/afz046
    [100] Park SW, Goodpaster BH, Strotmeyer ES, et al. (2006) Decreased muscle strength and quality in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes 55: 1813-1818. https://doi.org/10.2337/db05-1183
    [101] DeFronzo RA, Gunnarsson R, Björkman O, et al. (1985) Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J Clin Invest 76: 149-155. https://doi.org/10.1172/JCI111938
    [102] Ciaraldi TP, Mudaliar S, Barzin A, et al. (20005) Skeletal muscle GLUT1 transporter protein expression and basal leg glucose uptake are reduced in type 2 diabetes. J Clin Endocrinol Metab 90: 352-358. https://doi.org/10.1210/jc.2004-0516
    [103] Peterson MD, Rhea MR, Sen A, et al. (2010) Resistance exercise for muscular strength in older adults: a meta-analysis. Ageing Res Rev 9: 226-237. https://doi.org/10.1016/j.arr.2010.03.004
    [104] Schoenfeld BJ, Ogborn D, Krieger JW (2016) Effects of Resistance Training Frequency on Measures of Muscle Hypertrophy: A Systematic Review and Meta-Analysis. Sports Med 46: 1689-1697. https://doi.org/10.1007/s40279-016-0543-8
    [105] McGinley SK, Armstrong MJ, Boulé NG, et al. (2015) Effects of exercise training using resistance bands on glycaemic control and strength in type 2 diabetes mellitus: a meta-analysis of randomised controlled trials. Acta Diabetol 52: 221-230. https://doi.org/10.1007/s00592-014-0594-y
    [106] Liu Y, Ye W, Chen Q, et al. (2019) Resistance Exercise Intensity is Correlated with Attenuation of HbA1c and Insulin in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health 16: 140. https://doi.org/10.3390/ijerph16010140
    [107] Yuan X, Dai X, Liu L, et al. (2020) Comparing the effects of 6 months aerobic exercise and resistance training on metabolic control and β-cell function in Chinese patients with prediabetes: A multicenter randomized controlled trial. J Diabetes 12: 25-37. https://doi.org/10.1111/1753-0407.12955
    [108] Zhang H, Guo Y, Hua G, et al. (2024) Exercise training modalities in prediabetes: a systematic review and network meta-analysis. Front Endocrinol (Lausanne) 15: 1308959. https://doi.org/10.3389/fendo.2024.1308959
    [109] Gordon BA, Benson AC, Bird SR, et al. (2009) Resistance training improves metabolic health in type 2 diabetes: a systematic review. Diabetes Res Clin Pract 83: 157-175. https://doi.org/10.1016/j.diabres.2008.11.024
    [110] Dunstan DW, Daly RM, Owen N, et al. (2002) High-intensity resistance training improves glycemic control in older patients with type 2 diabetes. Diabetes Car 25: 1729-1736. https://doi.org/10.2337/diacare.25.10.1729
    [111] Che S, Meng M, Jiang Y, et al. (2022) Perceptions of exercise and exercise instruction in patients with type 2 diabetes mellitus and sarcopenia: a qualitative study. BMC Geriatr 22: 892. https://doi.org/10.1186/s12877-022-03519-0
    [112] Hsieh SS, Chueh TY, Huang CJ, et al. (2021) Systematic review of the acute and chronic effects of high-intensity interval training on executive function across the lifespan. J Sports Sci 39: 10-22. https://doi.org/10.1080/02640414.2020.1803630
    [113] Rynecki ND, Siracuse BL, Ippolito JA, et al. (2019) Injuries sustained during high intensity interval training: are modern fitness trends contributing to increased injury rates?. J Sports Med Phys Fitness 59: 1206-1212. https://doi.org/10.23736/S0022-4707.19.09407-6
    [114] Guthold R, Stevens GA, Riley LM, et al. (2018) Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled analysis of 358 population-based surveys with 1·9 million participants. Lancet Glob Health 6: e1077-e1086. https://doi.org/10.1016/S2214-109X(18)30357-7
    [115] Lee CL, Hsu WC, Cheng CF (2017) Physiological Adaptations to Sprint Interval Training with Matched Exercise Volume. Med Sci Sports Exerc 49: 86-95. https://doi.org/10.1249/MSS.0000000000001083
    [116] Lee CL, Kuo YH, Cheng CF (2018) Acute High-Intensity Interval Cycling Improves Postprandial Lipid Metabolism. Med Sci Sports Exerc 50: 1687-1696. https://doi.org/10.1249/MSS.0000000000001613
    [117] Gillen JB, Little JP, Punthakee Z, et al. (20112) Acute high-intensity interval exercise reduces the postprandial glucose response and prevalence of hyperglycaemia in patients with type 2 diabetes. Diabetes Obes Metab 14: 575-577. https://doi.org/10.1111/j.1463-1326.2012.01564.x
    [118] Little JP, Jung ME, Wright AE, et al. (2014) Effects of high-intensity interval exercise versus continuous moderate-intensity exercise on postprandial glycemic control assessed by continuous glucose monitoring in obese adults. Appl Physiol Nutr Metab 39: 835-841. https://doi.org/10.1139/apnm-2013-0512
    [119] Terada T, Wilson BJ, Myette-Côté E, et al. (2016) Targeting specific interstitial glycemic parameters with high-intensity interval exercise and fasted-state exercise in type 2 diabetes. Metabolism 65: 599-608. https://doi.org/10.1016/j.metabol.2016.01.003
    [120] Jelleyman C, Yates T, O'Donovan G, et al. (2015) The effects of high-intensity interval training on glucose regulation and insulin resistance: a meta-analysis. Obes Rev 16: 942-961. https://doi.org/10.1111/obr.12317
    [121] RezkAllah SS, Takla MK (2019) Effects of Different Dosages of Interval Training on Glycemic Control in People With Prediabetes: A Randomized Controlled Trial. Diabetes Spectr 32: 125-131. https://doi.org/10.2337/ds18-0024
    [122] Little JP, Safdar A, Wilkin GP, et al. (2010) A practical model of low-volume high-intensity interval training induces mitochondrial biogenesis in human skeletal muscle: potential mechanisms. J Physiol 588: 1011-1022. https://doi.org/10.1113/jphysiol.2009.181743
    [123] American Diabetes Association Primary Care Advisory Group.Introduction: Standards of Care in Diabetes-2024 Abridged for Primary Care Professionals. Clin Diabetes (2024) 42: 181. https://doi.org/10.2337/cd24-aint
    [124] Cai H, Li G, Zhang P, et al. (2017) Effect of exercise on the quality of life in type 2 diabetes mellitus: a systematic review. Qual Life Res 26: 515-530. https://doi.org/10.1007/s11136-016-1481-5
    [125] Sigal RJ, Armstrong MJ, Colby P, et al. (2013) Physical activity and diabetes. Can J Diabetes 37: S40-S44. https://doi.org/10.1016/j.jcjd.2013.01.018
    [126] Cuff DJ, Meneilly GS, Martin A, et al. (2003) Effective exercise modality to reduce insulin resistance in women with type 2 diabetes. Diabetes Care 26: 2977-2982. https://doi.org/10.2337/diacare.26.11.2977
    [127] Balducci S, Leonetti F, Di Mario U, et al. (2004) Is a long-term aerobic plus resistance training program feasible for and effective on metabolic profiles in type 2 diabetic patients?. Diabetes Care 27: 841-842. https://doi.org/10.2337/diacare.27.3.841
    [128] Balducci S, Alessi E, Cardelli P, et al. (2007) Effects of different modes of exercise training on glucose control and risk factors for complications in type 2 diabetic patients: a meta-analysis: response to Snowling and Hopkins. Diabetes Care 30: e25. https://doi.org/10.2337/dc06-2495
    [129] Schwingshackl L, Missbach B, Dias S, et al. (2014) Impact of different training modalities on glycaemic control and blood lipids in patients with type 2 diabetes: a systematic review and network meta-analysis. Diabetologia 57: 1789-1797. https://doi.org/10.1007/s00125-014-3303-z
    [130] Popkin BM, Adair LS, Ng SW (2012) Global nutrition transition and the pandemic of obesity in developing countries. Nutr Rev 70: 3-21. https://doi.org/10.1111/j.1753-4887.2011.00456.x
    [131] Palacios OM, Kramer M, Maki KC (2019) Diet and prevention of type 2 diabetes mellitus: beyond weight loss and exercise. Expert Rev Endocrinol Metab 14: 1-12. https://doi.org/10.1080/17446651.2019.1554430
    [132] Rowley WR, Bezold C, Arikan Y, et al. (2017) Diabetes 2030: Insights from Yesterday, Today, and Future Trends. Popul Health Manag 20: 6-12. https://doi.org/10.1089/pop.2015.0181
    [133] Gillies CL, Abrams KR, Lambert PC, et al. (2007) Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 334: 299. https://doi.org/10.1136/bmj.39063.689375.55
    [134] Lindström J, Ilanne-Parikka P, Peltonen M, et al. (2006) Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 368: 1673-1679. https://doi.org/10.1016/S0140-6736(06)69701-8
    [135] Knowler WC, Barrett-Connor E, Fowler SE, et al. (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346: 393-403. https://doi.org/10.1056/NEJMoa012512
    [136] Wing RR, Blair EH, Bononi P, et al. (1994) Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients. Diabetes Care 17: 30-36. https://doi.org/10.2337/diacare.17.1.30
    [137] Kirk E, Reeds DN, Finck BN, et al. (2009) Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. Gastroenterology 136: 1552-1560. https://doi.org/10.1053/j.gastro.2009.01.048
    [138] Astbury NM (2024) Interventions to improve glycaemic control in people living with, and at risk of developing type 2 diabetes. Diabetes Obes Metab 26: 39-49. https://doi.org/10.1111/dom.15855
    [139] Sobiecki JG, Imamura F, Davis CR, et al. (2023) A nutritional biomarker score of the Mediterranean diet and incident type 2 diabetes: Integrated analysis of data from the MedLey randomised controlled trial and the EPIC-InterAct case-cohort study. PLoS Med 20: e1004221. https://doi.org/10.1371/journal.pmed.1004221
    [140] Sharma BR, Jaiswal S, Ravindra PV (2022) Modulation of gut microbiota by bioactive compounds for prevention and management of type 2 diabetes. Biomed Pharmacother 152: 113148. https://doi.org/10.1016/j.biopha.2022.113148
    [141] Richardson VR, Smith KA, Carter AM (2013) Adipose tissue inflammation: feeding the development of type 2 diabetes mellitus. Immunobiology 218: 1497-1504. https://doi.org/10.1016/j.imbio.2013.05.002
    [142] El-Deyarbi M, Ahmed LA, King J, et al. (2024) Effect of structured diet with exercise education on anthropometry and lifestyle modification in patients with type 2 diabetes: A 12-month randomized clinical trial. Diabetes Res Clin Pract 213: 111754. https://doi.org/10.1016/j.diabres.2024.111754
    [143] Glavas C, Scott D, Sood S, et al. (2024) Exploring the Feasibility of Digital Voice Assistants for Delivery of a Home-Based Exercise Intervention in Older Adults With Obesity and Type 2 Diabetes Mellitus: Randomized Controlled Trial. JMIR Aging 7: e53064. https://doi.org/10.2196/53064
    [144] Derrick SA, Nguyen ST, Marthens JR, et al. (2023) A Mediterranean-Style Diet Improves the Parameters for the Management and Prevention of Type 2 Diabetes Mellitus. Medicina (Kaunas) 59: 1882. https://doi.org/10.3390/medicina59101882
    [145] Veleba J, Matoulek M, Hill M, et al. (2016) “A Vegetarian vs. Conventional Hypocaloric Diet: The Effect on Physical Fitness in Response to Aerobic Exercise in Patients with Type 2 Diabetes.” A Parallel Randomized Study. Nutrients 8: 671. https://doi.org/10.3390/nu8110671
    [146] Colberg SR, Sigal RJ, Yardley JE, et al. (2016) Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care 39: 2065-2079. https://doi.org/10.2337/dc16-1728
    [147] Pan XR, Li GW, Hu YH, et al. (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20: 537-544. https://doi.org/10.2337/diacare.20.4.537
    [148] Li G, Zhang P, Wang J, et al. (2008) The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 371: 1783-1789. https://doi.org/10.1016/S0140-6736(08)60766-7
    [149] Liu L, Ma X, Xu H, et al. (2021) Comparing the effects of 12 months aerobic exercise and resistance training on glucose metabolism among prediabetes phenotype: A explorative randomized controlled trial. Prim Care Diabetes 15: 340-346. https://doi.org/10.1016/j.pcd.2020.11.003
    [150] Rowan CP, Riddell MC, Gledhill N, et al. (2017) Aerobic Exercise Training Modalities and Prediabetes Risk Reduction. Med Sci Sports Exerc 49: 403-412. https://doi.org/10.1249/MSS.0000000000001135
    [151] AbouAssi H, Slentz CA, Mikus CR, et al. (2015) The effects of aerobic, resistance, and combination training on insulin sensitivity and secretion in overweight adults from STRRIDE AT/RT: a randomized trial. J Appl Physiol 118: 1474-1482. https://doi.org/10.1152/japplphysiol.00509.2014
    [152] Green DJ, Hopman MT, Padilla J, et al. (2017) Vascular Adaptation to Exercise in Humans: Role of Hemodynamic Stimuli. Physiol Rev 97: 495-528. https://doi.org/10.1152/physrev.00014.2016
    [153] Dreyer HC, Fujita S, Cadenas JG, et al. (2006) Resistance exercise increases AMPK activity and reduces 4E-BP1 phosphorylation and protein synthesis in human skeletal muscle. J Physiol 576: 613-624. https://doi.org/10.1113/jphysiol.2006.113175
    [154] Case N, Thomas J, Sen B, et al. (2011) Mechanical regulation of glycogen synthase kinase 3β (GSK3β) in mesenchymal stem cells is dependent on Akt protein serine 473 phosphorylation via mTORC2 protein. J Biol Chem 286: 39450-39456. https://doi.org/10.1074/jbc.M111.265330
    [155] Mu J, Brozinick JT, Valladares O, et al. (2001) A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell 7: 1085-1094. https://doi.org/10.1016/s1097-2765(01)00251-9
    [156] Geirsdottir OG, Arnarson A, Briem K, et al. (2012) Effect of 12-week resistance exercise program on body composition, muscle strength, physical function, and glucose metabolism in healthy, insulin-resistant, and diabetic elderly Icelanders. J Gerontol A Biol Sci Med Sci 67: 1259-1265. https://doi.org/10.1093/gerona/gls096
    [157] Malin SK, Gerber R, Chipkin SR, et al. (2012) Independent and combined effects of exercise training and metformin on insulin sensitivity in individuals with prediabetes. Diabetes Care 35: 131-136. https://doi.org/10.2337/dc11-0925
    [158] Dai X, Zhai L, Chen Q, et al. (2019) Two-year-supervised resistance training prevented diabetes incidence in people with prediabetes: A randomised control trial. Diabetes Metab Res Rev 35: e3143. https://doi.org/10.1002/dmrr.3143
    [159] Pate RR, Pratt M, Blair SN, et al. (1995) Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 273: 402-407. https://doi.org/10.1001/jama.273.5.402
    [160] Garber CE, Blissmer B, Deschenes MR, et al. (2011) American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc 43: 1334-1359. https://doi.org/10.1249/MSS.0b013e318213fefb
    [161] Imierska M, Kurianiuk A, Błachnio-Zabielska A (2020) The Influence of Physical Activity on the Bioactive Lipids Metabolism in Obesity-Induced Muscle Insulin Resistance. Biomolecules 10: 1665. https://doi.org/10.3390/biom10121665
    [162] Zanuso S, Sacchetti M, Sundberg CJ, et al. (2017) Exercise in type 2 diabetes: genetic, metabolic and neuromuscular adaptations. A review of the evidence. Br J Sports Med 51: 1533-1538. https://doi.org/10.1136/bjsports-2016-096724
    [163] Zouhal H, Zare-Kookandeh N, Haghighi MM, et al. (2021) Physical activity and adipokine levels in individuals with type 2 diabetes: A literature review and practical applications. Rev Endocr Metab Disord 22: 987-1011. https://doi.org/10.1007/s11154-021-09657-x
    [164] Li C, Bishop TRP, Imamura F, et al. (2024) Meat consumption and incident type 2 diabetes: an individual-participant federated meta-analysis of 1·97 million adults with 100 000 incident cases from 31 cohorts in 20 countries. Lancet Diabetes Endocrinol 12: 619-630. https://doi.org/10.1016/S2213-8587(24)00179-7
    [165] Albosta M, Bakke J (2021) Intermittent fasting: is there a role in the treatment of diabetes? A review of the literature and guide for primary care physicians. Clin Diabetes Endocrinol 7: 3. https://doi.org/10.1186/s40842-020-00116-1
  • This article has been cited by:

    1. Milena Vainieri, Guido Noto, Francesca Ferre, Laura C. Rosella, A Performance Management System in Healthcare for All Seasons?, 2020, 17, 1660-4601, 5590, 10.3390/ijerph17155590
    2. Ann Elizabeth Montgomery, Jack Tsai, John R. Blosnich, Demographic Correlates of Veterans’ Adverse Social Determinants of Health, 2020, 59, 07493797, 828, 10.1016/j.amepre.2020.05.024
    3. Hadi Kharrazi, Roland Gamache, Jonathan Weiner, 2020, Chapter 5, 978-3-030-41214-2, 59, 10.1007/978-3-030-41215-9_5
    4. John R. Blosnich, Ann Elizabeth Montgomery, Laura D. Taylor, Melissa E. Dichter, Adverse social factors and all-cause mortality among male and female patients receiving care in the Veterans Health Administration, 2020, 141, 00917435, 106272, 10.1016/j.ypmed.2020.106272
    5. Hsien-Yen Chang, Elham Hatef, Xiaomeng Ma, Jonathan P. Weiner, Hadi Kharrazi, Impact of Area Deprivation Index on the Performance of Claims-Based Risk-Adjustment Models in Predicting Health Care Costs and Utilization, 2020, 1942-7891, 10.1089/pop.2020.0135
    6. Chau Trinh-Shevrin, Applying a Population Health Equity Framework in the Clinical Setting—Incorporating Social and Behavioral Determinants of Health Into Estimations of Risk, 2020, 3, 2574-3805, e2021771, 10.1001/jamanetworkopen.2020.21771
    7. Lisa M. McElroy, Allan D. Kirk, Eudaimonia: An Aristotelian approach to transplantation, 2021, 1600-6135, 10.1111/ajt.16487
    8. Ronald C. Kessler, Mark S. Bauer, Todd M. Bishop, Olga V. Demler, Steven K. Dobscha, Sarah M. Gildea, Joseph L. Goulet, Elizabeth Karras, Julie Kreyenbuhl, Sara J. Landes, Howard Liu, Alex R. Luedtke, Patrick Mair, William H. B. McAuliffe, Matthew Nock, Maria Petukhova, Wilfred R. Pigeon, Nancy A. Sampson, Jordan W. Smoller, Lauren M. Weinstock, Robert M. Bossarte, Using Administrative Data to Predict Suicide After Psychiatric Hospitalization in the Veterans Health Administration System, 2020, 11, 1664-0640, 10.3389/fpsyt.2020.00390
    9. Kathleen Brewer-Smyth, 2022, Chapter 6, 978-3-031-08800-1, 155, 10.1007/978-3-031-08801-8_6
    10. Jeslyn Rodriguez, Yuri Quintana, Understanding the social determinants of health and genetic factors contributing to the differences observed in COVID-19 incidence and mortality between underrepresented and other communities, 2022, 114, 00279684, 430, 10.1016/j.jnma.2022.04.002
    11. Anand K. Bery, Laura J. Anzaldi, Cynthia M. Boyd, Bruce Leff, Hadi Kharrazi, Potential value of electronic health records in capturing data on geriatric frailty for population health, 2020, 91, 01674943, 104224, 10.1016/j.archger.2020.104224
    12. N.J. Kane, X. Wang, M.M. Gerkovich, M. Breitkreutz, B. Rivera, H. Kunchithapatham, M.A. Hoffman, The Envirome Web Service: Patient context at the point of care, 2021, 119, 15320464, 103817, 10.1016/j.jbi.2021.103817
    13. Chanita Hughes Halbert, Melanie Jefferson, Caitlin G. Allen, Oluwole A. Babatunde, Richard Drake, Peggi Angel, Stephen J. Savage, Lewis Frey, Michael Lilly, Ted Obi, Jihad Obeid, Racial Differences in Patient Portal Activation and Research Enrollment Among Patients With Prostate Cancer, 2021, 2473-4276, 768, 10.1200/CCI.20.00131
    14. Yoosun Park, James W. Quinn, Philip M. Hurvitz, Jana A. Hirsch, Jeff Goldsmith, Kathryn M. Neckerman, Gina S. Lovasi, Andrew G. Rundle, Addressing patient’s unmet social needs: disparities in access to social services in the United States from 1990 to 2014, a national times series study, 2022, 22, 1472-6963, 10.1186/s12913-022-07749-1
    15. Mindy C. DeRouen, Caroline A. Thompson, Alison J. Canchola, Anqi Jin, Sixiang Nie, Carmen Wong, Jennifer Jain, Daphne Y. Lichtensztajn, Yuqing Li, Laura Allen, Manali I. Patel, Yihe G. Daida, Harold S. Luft, Salma Shariff-Marco, Peggy Reynolds, Heather A. Wakelee, Su-Ying Liang, Beth E. Waitzfelder, Iona Cheng, Scarlett L. Gomez, Integrating Electronic Health Record, Cancer Registry, and Geospatial Data to Study Lung Cancer in Asian American, Native Hawaiian, and Pacific Islander Ethnic Groups, 2021, 30, 1055-9965, 1506, 10.1158/1055-9965.EPI-21-0019
    16. Lisa Muirhead, Katharina V. Echt, Andrea M. Alexis, Anna Mirk, Social Determinants of Health, 2022, 57, 00296465, 329, 10.1016/j.cnur.2022.04.002
    17. Heidi Cramm, D Norris, N T Fear, R Dekel, Military families and military-to-civilian transition: the current state of play, 2021, 2633-3767, bmjmilitary-2021-001815, 10.1136/bmjmilitary-2021-001815
    18. Hadi Kharrazi, David Horrocks, Jonathan Weiner, 2023, 9780323908023, 523, 10.1016/B978-0-323-90802-3.00011-3
    19. Chintan J. Pandya, JunBo Wu, Elham Hatef, Hadi Kharrazi, Latent Class Analysis of Social Needs in Medicaid Population and Its Impact on Risk Adjustment Models, 2024, 62, 0025-7079, 724, 10.1097/MLR.0000000000001961
    20. Dmytro S Lituiev, Benjamin Lacar, Sang Pak, Peter L Abramowitsch, Emilia H De Marchis, Thomas A Peterson, Automatic extraction of social determinants of health from medical notes of chronic lower back pain patients, 2023, 30, 1067-5027, 1438, 10.1093/jamia/ocad054
    21. Seshadri C Mudumbai, Han He, Ji-Qing Chen, Aditi Kapoor, Samantha Regala, Edward R Mariano, Randall S Stafford, Christian C Abnet, Ruth M Pfeiffer, Neal D Freedman, Arash Etemadi, Opioid use in cancer patients compared with noncancer pain patients in a veteran population, 2024, 8, 2515-5091, 10.1093/jncics/pkae012
    22. Elvira E. Jimenez, Ann-Marie Rosland, Susan E. Stockdale, Ashok Reddy, Michelle S. Wong, Natasha Torrence, Alexis Huynh, Evelyn T. Chang, Implementing evidence-based practices to improve primary care for high-risk patients: study protocol for the VA high-RIsk VETerans (RIVET) type III effectiveness-implementation trial, 2024, 5, 2662-2211, 10.1186/s43058-024-00613-9
    23. Jodi Segal, Robert DeGrazia, Samantha Pitts, Kristal Brown, Maile Taualii, Comprehensive Diabetes Assessment Instrument for Patients With Type 2 Diabetes, 2023, 14, 2150-1319, 10.1177/21501319231204590
    24. Myia S. Williams, Edgardo Cigaran, Sabrina Martinez, Jose Marino, Paulina Barbero, Alyson K. Myers, Ralph J. DiClemente, Nicole Goris, Valeria Correa Gomez, Dilcia Granville, Josephine Guzman, Yael T. Harris, Myriam Kline, Martin L. Lesser, Amgad N. Makaryus, Lawrence M. Murray, Samy I. McFarlane, Vidhi H. Patel, Jennifer Polo, Roman Zeltser, Renee Pekmezaris, COVID-19 stressors for Hispanic/Latino patients living with type 2 diabetes: a qualitative study, 2023, 4, 2673-6616, 10.3389/fcdhc.2023.1070547
    25. Kriyana P Reddy, Saania Mirpuri, Cara L Berkowitz, Elizabeth M de Jesus, Sarah B Hulse, Julia T Lewandowski, Kerry Q Coughlin, Merium L Burwell, Robin Evans, Jennifer Galetta, Sharon Rivera Sanchez, Trudy L Buckingham, Victoria Livingstone, Anne Marie McCarthy, Peter E Gabriel, Christine E Edmonds, Tamara J Cadet, Oluwadamilola M Fayanju, Implementing social and behavioral determinants of health data collection: insights from a pragmatic trial, 2025, 9, 2515-5091, 10.1093/jncics/pkaf040
  • Reader Comments
  • © 2025 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(842) PDF downloads(42) Cited by(0)

Figures and Tables

Figures(3)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog